T

Travere Therapeutics
D

TVTX

29.130
USD
-4.99
(-14.62%)
قبل الجلسة
حجم التداول
62
الربح لكل سهم
1
العائد الربحي
-
P/E
-28
حجم السوق
2,606,328,886
أصول ذات صلة المقالات

العنوان: Travere Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.